Privacy Policy
Signals Blog

Contributors

Categories

Comparing two snapshots of RM taken a decade apart

When Signals first burst onto the scene in 2012, the potential of the regenerative medicine industry still hadn’t set in for many. When the Alliance for Regenerative Medicine (ARM) published its first state of the industry report in 2012, the ARM chairman at the time,...

Right Turn: Looking back on 10 amazing years at Signals

This month is the 10-year anniversary of when Lisa Willemse and I launched Signals. As you would imagine, blogs come and go so 10 years is a significant milestone. It is also my 10-year anniversary at CCRM and when I was introduced to the regenerative medicine field....

Genetically engineering cures for sickle cell disease

If I were to ask you to think of a genetic disease that should be a priority for gene therapy research, you might say breast cancer, Huntington’s, or cystic fibrosis. And these are all great candidates. But I’d say you’re missing a big one. Sickle cell disease (SCD)...

Right Turn: Funding a cure

If Chip Wilson isn’t a name you recognize, I’m confident you’ve heard of Lululemon. Lululemon is the activewear company that Mr. Wilson built. Born in the U.S., but educated and living in Canada, he’s a billionaire who is using his money to find a cure for...

Subscribe to Signals

Subscribe to our blog list to receive the latest news and updates.

You have Successfully Subscribed!